Pantoprazole 20 mg/40mg for gastroesophageal reflux disease (GERD).
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2014
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms PANTHER
- Sponsors Takeda Pharmaceuticals International GmbH
- 17 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Dec 2007 New trial record.